Healios K.K.
HLOSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.31 | 0.25 | 0.00 | -0.16 |
| FCF Yield | -1.14% | -1.68% | -2.78% | -3.03% |
| EV / EBITDA | 105.19 | -59.26 | -37.07 | -22.90 |
| Quality | ||||
| ROIC | -6.28% | -8.31% | -7.12% | -4.45% |
| Gross Margin | -494.74% | -209.09% | 23.68% | -66.67% |
| Cash Conversion Ratio | -1.33 | 0.38 | 0.30 | -2.26 |
| Growth | ||||
| Revenue 3-Year CAGR | -23.43% | -13.82% | 89.80% | 83.93% |
| Free Cash Flow Growth | 99.33% | -5.94% | -33.45% | -300.00% |
| Safety | ||||
| Net Debt / EBITDA | -6.08 | 4.77 | 4.18 | 1.27 |
| Interest Coverage | 0.00 | -0.67 | -0.42 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 724.82 | 284.32 | -512.07 | -577.00 |